Cervical Cancer Screening using Cytology and Human Papillomavirus Testing (CG-MED-43) not implemented

 

In the October 2017 edition of the Network Update, we announced a new coverage guideline, Cervical Cancer Screening Using Cytology and Human Papillomavirus Testing (CG-MED-53) to be effective January 1, 2018. Please be advised that CG-MED-53 was not implemented.